Medicure (CVE:MPH) Shares Cross Above 50-Day Moving Average – Time to Sell?

Medicure Inc. (CVE:MPH) shares crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$1.19 and traded as high as C$1.25. Medicure shares last traded at C$1.25, with a volume of 3,800 shares trading hands.

Medicure Stock Up 12.6%

The company has a debt-to-equity ratio of 4.65, a current ratio of 2.03 and a quick ratio of 1.29. The company has a market capitalization of C$13.05 million, a PE ratio of -3.79 and a beta of 1.02. The business has a 50-day moving average of C$1.19 and a 200 day moving average of C$1.16.

About Medicure

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications.